Showing results (111-120 of 124) with videos related to
Sort By:
Pageof 13
The AAPS Journal|June 16, 2010
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technologyClaudia Fredolini, Francesco Meani, Alessandra Luchini, et al.BMC Cancer|July 6, 2010
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancerEmiliano Cocco, Francesca Casagrande, Stefania Bellone, et al.The New England Journal of Medicine|September 8, 2010
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancerIgnace Vergote, Claes G Tropé, Frédéric Amant, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificitiesEnrica Calura, Robert Fruscio, Lara Paracchini, et al.International Journal of Cancer|June 11, 2015
Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancerEmiliano Cocco, Erik M Shapiro, Sara Gasparrini, et al.Plos One|November 6, 2009
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patientsBih-Rong Wei, Shelley B Hoover, Mark M Ross, et al.Journal of Experimental & Clinical Cancer Research : CR|May 10, 2017
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patientsRenata A Tassi, Paola Todeschini, Eric R Siegel, et al.Advances in Nutrition (Bethesda, Md.)|July 16, 2017
Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and PerspectivesPaolo Magni, Dennis M Bier, Sergio Pecorelli, et al.Proceedings of the National Academy of Sciences of the United States of America|January 30, 2013
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinomaSiming Zhao, Murim Choi, John D Overton, et al.Proceedings of the National Academy of Sciences of the United States of America|December 26, 2018
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitorsCharles Li, Elena Bonazzoli, Stefania Bellone, et al.Pageof 13